Gilead goes after an HIV cure; Veloxis wins orphan status;

@FierceBiotech: Hunting a fast approval in lung cancer, Roche racks up a positive PhII for 'atezo.' Article | Follow @FierceBiotech

@JohnCFierce: Heard the latest Kite rumor? CEO says it ain't so. More | Follow @JohnCFierce

> Now that Gilead ($GILD) has cured hep C--with rivals looking to compete on market share--Bloomberg reviews the big biotech's next-gen work on HIV, including a potential cure dubbed GS-9620 that employs a "kick and kill" approach to uprooting and extinguishing the virus. Story

> Denmark's Veloxis Pharmaceuticals (OMX: VELO) announced that the FDA granted EnvarsusXR orphan drug status for prophylaxis of organ rejection in patients who convert from immediate-release tacrolimus. Release

Medical Device News

@FierceMedDev: Myriad snags Medicare coverage for prostate cancer test. News from FierceDiagnostics | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Bad news in California: Boston Sci to close to two facilities, Abbott cuts 160+ employees. Report | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: NOWDiagnostics gets FDA blessing for one-step pregnancy test. Story | Follow @EmilyWFierce

> GE gets FDA nod for low-dose computer CT lung cancer screening device. Story

> FDA: International regs don't protect patients from contaminated intraocular lenses. Article

Pharma News

@FiercePharma: ICYMI from FiercePharmaAsia: GeneWeave fits China antibiotic resistance fight, Decheng says. More | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Sun U.S. sales gut-kicked by supply constraints as it works on FDA concerns at Halol plant. Story | Follow @EricPFierce

@CarlyHFierce: Probing lawmakers grill Valeant on price hikes. FiercePharma article | Follow @CarlyHFierce

> India, EU scramble to resolve drug ban so trade talks don't go down the drain. Story

> Stalwart brands from AZ, Glaxo and Sanofi top ranks of most-prescribed meds. Article

Animal Health News

> ImmuCell Q2 sales up, but not at levels reached earlier in the year. Item

> Merck debuts Fortegra in South America to combat coccidiosis in broilers. Story

> Frozen raw cat food recall by Northwest Farm Food Coop. More

> Parnell Pharmaceuticals says first-half losses narrow as it gears up pipeline. Report

> In wake of bird flu, Minnesota turkey producers slowly restocking flocks. Article

Biotech IT News

> Soon-Shiong allies with PA biomedical centers to further genomic research. News

> FDA adds alerts to Android drug shortages app. Item

> Google hooks up with DexCom to apply miniaturized electronics to diabetes monitoring. Story

> Trader accused of using hacked newswires to make $2.3M from Dendreon implosion. Article

> BioClinica makes eClinical suite available through a range of cloud options. Report

Pharma Marketing News

> FDA approves Purdue's controversial OxyContin for kids aged 11 to 16. Item

> Mylan hopes Disney can add new magic to its allergy-fighting kingdom. Report

> BMS revives Orencia DTC advertising after two-year absence. Story

> Has Kim Kardashian ruined pharma marketing, too? Fallout from the infamous Instagram post. More

> Sanofi adds its sales heft to Relypsa's forthcoming patiromer launch. Article

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.